Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 396

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 396
---
 net operating loss credit.

A reconciliation of the beginning
and ending amount of the liability for uncertain tax positions, excluding potential interest and penalties, is as follows:

| Balance as of December 31, 2023                         |     | $ | 459,000 |
| Increase/(decrease) based on current year tax positions |     |   |  79,000 |
| Increase/(decrease) for prior year tax positions        |     |   |       - |
| Lapses of applicable statutes                           |     |   |       - |
| Balance as of December 31, 2024                         |     | $ | 538,000 |

NOTE 13 – 401(k) RETIREMENT SAVINGS PLAN The Company sponsors a 401(k) defined contribution plan covering eligible employees who elect to participate. The Company is allowed to make discretionary profit sharing and 401(k) matching contributions as defined in the plan and as approved by the Board of Directors. The Company’s contributions for the period from February 14, 2024 through December 31, 2024 was $ 44,077and Predecessor contributions during the period from January 1, 2024 through February 13, 2024 was $ 8,657. The Predecessor made contributions of $ 63,344during the year ended December 31, 2023. F-60

NOTE 14 – RELATED-PARTY TRANSACTIONS

In February 2024, we issued
and sold an aggregate of shares of Series A Preferred Stock, Series A Common Warrants and Preferred Warrants, at a price
of $ per share of Series A Preferred Stock, for aggregate cash proceeds of approximately $ million, plus additional cash proceeds
of up to $ million if the Preferred Warrants are exercised.

The following table summarizes
the shares of our Series A Preferred Stock issued to our related parties:

| Purchasers                              |     | Shares             
 of                 
 Series A Preferred 
 Stock              |       |     | Total    
 Purchase 
 Price    |           |
|:----------------------------------------|:----|:-------------------|------:|:----|:---------|----------:|
| Daniel Corey(1)                         |     |                    |   150 |     | $        |   150,000 |
| Atwood-Edminster Trust dtd 4-2-2000 (2) |     |                    | 1,002 |     | $        | 1,002,000 |